HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines.

Abstract
In the 1980s the outcome of patients with herpes simplex encephalitis was shown to be dramatically improved with aciclovir treatment. Delays in starting treatment, particularly beyond 48 h after hospital admission, are associated with a worse prognosis. Several comprehensive reviews of the investigation and management of encephalitis have been published. However, their impact on day-to day clinical practice appears to be limited. The emergency management of meningitis in children and adults was revolutionised by the introduction of a simple algorithm as part of management guidelines. In February 2008 a group of clinicians met in Liverpool to begin the development process for clinical care guidelines based around a similar simple algorithm, supported by an evidence base, whose implementation is hoped would improve the management of patients with suspected encephalitis.
AuthorsT Solomon, B D Michael, P E Smith, F Sanderson, N W S Davies, I J Hart, M Holland, A Easton, C Buckley, R Kneen, N J Beeching, National Encephalitis Guidelines Development and Stakeholder Groups
JournalThe Journal of infection (J Infect) Vol. 64 Issue 4 Pg. 347-73 (Apr 2012) ISSN: 1532-2742 [Electronic] England
PMID22120595 (Publication Type: Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012. Published by Elsevier Ltd.
Chemical References
  • Antiviral Agents
Topics
  • Adult
  • Antiviral Agents (therapeutic use)
  • Disease Management
  • Encephalitis, Herpes Simplex (drug therapy)
  • Encephalitis, Viral (diagnosis, epidemiology, pathology, therapy)
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: